{
  "ticker": "MYX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964586",
  "id": "02964586",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250701",
  "time": "1557",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250701/pdf/06lblxtnj2l6yd.pdf",
  "summary": "### **Summary of Notice of Ceasing to be a Substantial Holder (ASX Form 605) \u2013 Mayne Pharma Group Ltd (ASX: MYX)**  \n\n- **Substantial holder ceased:** First Sentier Investors (Australia) IM Ltd (ACN 114 194 311) and related entities (see Annexure A for full list).  \n- **Date ceased being substantial holder:** 27/06/2025.  \n- **Changes in relevant interests (via First Sentier Investors RQI Pty Ltd ACN 133 312 017):**  \n  - **Sales on 27/06/2025:**  \n    - 4,606 shares sold for **$23,134.56** (total votes affected: 4,606).  \n    - 68,988 shares sold for **$346,506.03** (total votes affected: 68,988).  \n    - 14,569 shares sold for **$73,175.72** (total votes affected: 14,569).  \n  - **Total shares disposed:** **88,163** fully paid ordinary shares.  \n\n### **Key Takeaway:**  \nSignificant reduction in substantial holding (~88k shares sold) by First Sentier Investors group. Monitor for further disposals or market reaction.  \n\n*(Omitted: Legal boilerplate, full list of associates, non-material annexure details.)*",
  "usage": {
    "prompt_tokens": 1816,
    "completion_tokens": 292,
    "total_tokens": 2108,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-01T06:28:41.056353"
}